Key result
Culture-expanded cardiosphere-derived cells from adult donors displayed a distinct transcriptional profile with greater cell cycle activity, prominent paracrine growth factor release, and superior in vitro vascular tube formation compared to c-kitpos progenitor cells.
Why the study?
Do donor age and isolation method affect the phenotypic and functional characteristics of human cardiac progenitor cells?
Do donor age and isolation method affect the phenotypic and functional characteristics of human cardiac progenitor cells?
Cardiac progenitor cells exhibit donor age- and isolation method-specific characteristics that influence their angiogenic and differentiation potential, which may explain variable outcomes in cell-based cardiac repair trials.
May inform cell source selection in regenerative trials; leaves open optimal progenitor for cardiac repair.
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has intensified clinical trials to induce cardiac regeneration in the adult mammalian heart using different progenitor cell types. We hypothesized that donor age-related phenotypic and functional characteristics of cardiac progenitor cells (CPC) account for mixed results of cell-based cardiac repair. We compared expression profiles and cell turnover rates of human heart-derived c-kit pos progenitors (c-kit pos CPC) and cardiosphere-derived cells (CDC) from young and adult donor origin and studied their in vitro angiogenic and cardiac differentiation potential, which can be relevant for cardiac repair. We report that 3-dimensional CDC expansion recapitulates a conducive environment for growth factor and cytokine release from adult donor cells (aCDC) that optimally supports vascular tube formation and vessel sprouting. Transdifferentiation capacity of c-kit pos CPCs and CDCs towards cardiomyocyte-like cells was modest, however, most notable in young c-kit pos cells and adult CDCs. Progenitors isolated with different methods thus show cell- and donor-specific characteristics that may account for variable contributions in functional myocardial recovery.
No takes yet. Share an insight, caveat, or question.
Walravens et al. (2018) studied Congenital heart disease (young) and advanced ischemic/valvular disease (adults) (n=48). Donor age and cell isolation method (Cardiosphere-derived cells vs c-kitpos progenitor cells) vs. Young vs adult donors; CDCs vs c-kitpos CPCs was evaluated on In vitro molecular signature, proliferation, and angiogenic potential. Culture-expanded cardiosphere-derived cells from adult donors displayed a distinct transcriptional profile with greater cell cycle activity, prominent paracrine growth factor release, and superior in vitro vascular tube formation compared to c-kitpos progenitor cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: